E Fund Management Co., Ltd. Viking Therapeutics, Inc. Transaction History
E Fund Management Co., Ltd.
- $1.8 Billion
- Q2 2024
A detailed history of E Fund Management Co., Ltd. transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, E Fund Management Co., Ltd. holds 20,380 shares of VKTX stock, worth $1.26 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
20,380
Previous 6,038
237.53%
Holding current value
$1.26 Million
Previous $495,000
118.18%
% of portfolio
0.06%
Previous 0.03%
Shares
8 transactions
Others Institutions Holding VKTX
# of Institutions
442Shares Held
63.3MCall Options Held
6.23MPut Options Held
2.97M-
Vanguard Group Inc Valley Forge, PA10.1MShares$626 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$374 Million0.01% of portfolio
-
State Street Corp Boston, MA5.12MShares$318 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.25MShares$140 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA1.86MShares$115 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $4.75B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...